FDA panel discusses antidepressant label changes

FDA's Psychopharmacologic Drugs Advisory Committee voted 6-2 Wednesday to recommend that the agency modify language contained

Read the full 161 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE